These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 17408387

  • 1. Retinal pigment epithelium tears following intravitreal ranibizumab therapy.
    Kiss C, Michels S, Prager F, Geitzenauer W, Schmidt-Erfurth U.
    Acta Ophthalmol Scand; 2007 Dec; 85(8):902-3. PubMed ID: 17408387
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retinal pigment epithelial tears in ranibizumab-treated eyes.
    Smith BT, Kraus CL, Apte RS.
    Retina; 2009 Mar; 29(3):335-9. PubMed ID: 19174716
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM, Yoganathan P, Chien FY, Corcóstegui IA, Blumenkranz MS, Deramo VA, Elner SG, Fastenberg DA, Johnson MW, López M, Mateo C, Moshfeghi DM, Navarro R, Rosenblatt BJ, Sanislo SR, Saxe SJ, Zacks DN.
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.
    Garg S, Brod R, Kim D, Lane RG, Maguire J, Fischer D.
    Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594
    [Abstract] [Full Text] [Related]

  • 10. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU.
    Acta Ophthalmol Scand; 2006 Dec; 84(6):833-4. PubMed ID: 17083554
    [No Abstract] [Full Text] [Related]

  • 11. Macular hole following intravitreal ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration.
    Querques G, Souied EH, Soubrane G.
    Acta Ophthalmol; 2009 Mar; 87(2):235-7. PubMed ID: 19292858
    [No Abstract] [Full Text] [Related]

  • 12. Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD.
    Apte RS.
    Int Ophthalmol; 2007 Feb; 27(1):59-61. PubMed ID: 17415530
    [Abstract] [Full Text] [Related]

  • 13. Tears of the retinal pigment epithelium: an old problem in a new era.
    Chang LK, Sarraf D.
    Retina; 2007 Jun; 27(5):523-34. PubMed ID: 17558312
    [Abstract] [Full Text] [Related]

  • 14. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration.
    Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU, Inhoffen W.
    Eye (Lond); 2009 Mar; 23(3):694-702. PubMed ID: 18239678
    [Abstract] [Full Text] [Related]

  • 15. Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.
    Lee GK, Lai TY, Chan WM, Lam DS.
    Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1225-7. PubMed ID: 17287977
    [Abstract] [Full Text] [Related]

  • 16. A new grading system for retinal pigment epithelial tears.
    Sarraf D, Reddy S, Chiang A, Yu F, Jain A.
    Retina; 2010 Aug; 30(7):1039-45. PubMed ID: 20458264
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
    Spandau UH, Jonas JB.
    Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
    [Abstract] [Full Text] [Related]

  • 19. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
    Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW, Esquiabro M.
    Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.